In a new report, the American College of Cardiology emphasized five key ways to enhance care for elderly patients presenting with cognitive and frailty issues.

Justine Varieur Turco held several leadership positions with the American College of Cardiology over the years. She is also a former Cardiovascular Business editor.

Cardiac CT scans may give clinicians a way to visualize the effects of environmental exposure before cardiovascular events even occur.

The study's authors reviewed data from more than 50,000 patients, confirming that patients given tirzepatide were less likely to die or experience a heart attack than those given an older diabetes medication.

The newly cleared pVasc NET includes a dual-layer filter not available on the company's previous devices. 

Bill Shields, who spent a 15 years with Medtronic’s structural heart division, will now be helping lead a startup focused on tricuspid valve treatments. 

The SPARC trial will enroll up to 125 patients with peripheral artery disease. 

The standard of care for hypertrophic cardiomyopathy has undergone a lot of change in recent years. Many more changes are likely on the way.

Cardiac imaging expert Ron Blankstein, MD, Brigham and Women's Hospital, provides an overview of how CCTA may soon become a paradigm shift in cardiac prevention.

Flu vaccines were also associated with lower rates of all-cause mortality, myocardial infarction and heart failure, researchers noted. 

CCTA can show the regression of atherosclerosis due to drug therapies over time, so it may be a good tool to identify those patients who need of more aggressive therapy.

Tauklarify, also known as MK-6240, is a radiodiagnostic agent indicated for positron emission tomography scans of adults suspected of having the degenerative brain disease. 

The revisions provide guidance on radiation therapy across resectable, locally advanced, recurrent, metastatic and palliative disease.